More on EOLS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+85.2% Growth)
- Ratings (7.7 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Evolus (NQ:EOLS)
Delayed: 6.68 -0.05 (0.74%)
Prev. Close $6.73  
Open$6.76 
52 Wk High$ 
52 Wk Low$ 
Day High$6.90 
Day Low$6.62 
P/E N/A  
EPS$ 
Volume499,954 


Jun 15, 2026 06:23 AM Form EFFECT Evolus, Inc.
Jun 12, 2026 04:19 PM Form 8-K Evolus, Inc. For: Jun 11
Jun 5, 2026 04:49 PM Evolus (EOLS) files $250M mixed shelf
Jun 5, 2026 04:46 PM Form S-3 Evolus, Inc.
May 19, 2026 08:30 AM Evolus to Participate in The Jefferies Global Healthcare Conference
May 11, 2026 08:30 AM Evolus launches Estyme dermal filler collection in Europe
May 11, 2026 08:30 AM Evolus launches Estyme hyaluronic acid gels in Europe
May 11, 2026 08:30 AM Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe
May 4, 2026 05:01 PM Form 10-Q Evolus, Inc. For: Mar 31
May 4, 2026 04:13 PM Evolus (EOLS) Misses Q1 EPS by 5c
View All Articles

Entities mentioned with EOLS

View All Entities